{
    "clinical_study": {
        "@rank": "92473", 
        "arm_group": [
            {
                "arm_group_label": "Marketed cow milk-based premature infant formula", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Marketed extensively hydrolyzed casein infant formula", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the use of a hypoallergenic infant formula containing an extensively hydrolyzed\n      protein source for routine nutrition."
        }, 
        "brief_title": "Tolerance of an Extensively Hydrolyzed Protein Infant Formula Versus a Premature Infant Formula", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Feeding Intolerance", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Premature infant 28 to 33 weeks gestational age, inclusive, at birth\n\n          -  Infant has never received enteral feedings or current enteral intake is less than 30\n             mL/kg/day\n\n          -  Birth weight is greater than or equal to 700g to 1750g\n\n          -  Appropriate birth weight for gestational age\n\n          -  Singleton or twin birth\n\n          -  Signed Informed consent\n\n        Exclusion Criteria:\n\n          -  Infant's mother plans to exclusively breast feed\n\n          -  5 minute APGAR score is less than or equal to 4\n\n          -  Major surgery that required general anesthesia prior to randomization\n\n          -  Ventilator-dependent or requiring greater than 40% FiO2 on day of randomization\n\n          -  Grade III or IV intraventricular hemorrhage diagnosed prior to randomization\n\n          -  Infant is currently participating in another clinical study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01987154", 
            "org_study_id": "6020"
        }, 
        "intervention": [
            {
                "arm_group_label": "Marketed cow milk-based premature infant formula", 
                "intervention_name": "Marketed cow milk-based premature infant formula", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Marketed extensively hydrolyzed casein infant formula", 
                "intervention_name": "Marketed extensively hydrolyzed casein infant formula", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Caseins"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 10, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bari", 
                    "country": "Italy", 
                    "state": "Apulia", 
                    "zip": "70124"
                }, 
                "name": "Azienda Ospedaliera \"Ospedale Policlinico Consorziale\" di Bari"
            }, 
            "investigator": {
                "last_name": "Mariella Baldassarree, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Tolerance of an Extensively Hydrolyzed Protein Infant Formula Versus a Premature Infant Formula", 
        "overall_contact": {
            "email": "nancy.moore@mjn.com", 
            "last_name": "Nancy Moore", 
            "phone": "8124831847"
        }, 
        "overall_official": {
            "affiliation": "Universita degli Studi di Bari", 
            "last_name": "Mariella Baldassarre, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italian: Medicines Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Enteral intake (ml/kg/day)", 
            "safety_issue": "Yes", 
            "time_frame": "Daily for 14 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01987154"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Body Weight (g)", 
                "safety_issue": "Yes", 
                "time_frame": "Daily for 14 days"
            }, 
            {
                "description": "Gastric residuals, regurgitation(>1 ml), fecal output (number of stools per day)", 
                "measure": "Feeding Tolerance", 
                "safety_issue": "No", 
                "time_frame": "Daily for 14 days"
            }, 
            {
                "description": "Apnea and/or bradycardia events, use of supplemental oxygen, use of mechanical ventilation", 
                "measure": "Respiratory status", 
                "safety_issue": "Yes", 
                "time_frame": "Daily for 14 days"
            }, 
            {
                "description": "Fecal calprotectin, alpha and beta defensins, TNF alpha, gastric ultrasound", 
                "measure": "Gut Inflammation", 
                "safety_issue": "No", 
                "time_frame": "Once at Study Day 14"
            }, 
            {
                "measure": "Confirmed or suspected sepsis or necrotizing enterocolitis", 
                "safety_issue": "Yes", 
                "time_frame": "Daily for 14 days"
            }, 
            {
                "measure": "Date of hospital discharge", 
                "safety_issue": "No", 
                "time_frame": "Once at hospital discharge"
            }, 
            {
                "description": "length (cm) and head circumference (cm)", 
                "measure": "Growth", 
                "safety_issue": "Yes", 
                "time_frame": "Study Days 1, 7, and 14"
            }
        ], 
        "source": "Mead Johnson Nutrition", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mead Johnson Nutrition", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}